Ranitidine in the treatment of non-steroidal anti-inflammatory drug associated gastric and duodenal ulcers.

M J Lancaster-Smith, M E Jaderberg, D A Jackson

Department of Medicine, Queen Mary's Hospital, Kent.

In a multicentre study the effect of ranitidine on healing non-steroidal anti-inflammatory drug (NSAID) associated peptic ulcers was compared in a group of patients who had stopped NSAID treatment with another group who continued with NSAID treatment. A total of 190 patients with confirmed ulcers were randomised to continue or stop NSAID treatment. All patients in addition received ranitidine 150 mg twice daily. Patients were endoscopically monitored at four, eight, and 12 weeks. Gastric ulcers at eight weeks had healed in 63% of those taking NSAIDs compared with 95% of those who had stopped NSAID treatment. For duodenal ulcer the healing rates at eight weeks were 84% in the group continuing NSAIDs compared with 100% in those who stopped NSAIDs. The differences in healing rates were statistically significant for both gastric ulcer (p = 0.001) and for duodenal ulcer (p = 0.006). At 12 weeks, 79% of gastric ulcers and 92% of duodenal ulcers were healed in the group continuing with NSAIDs. All patients with gastric and duodenal ulcers who stopped taking NSAIDs were healed at 12 weeks. The study shows that ranitidine 150 mg twice daily effectively heals NSAID associated peptic ulcers. Healing is more successful when NSAID treatment stops but even if these drugs are continued, substantial healing rates are achievable.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Ranitidine and non-steroidal anti-inflammatory drug (NSAID) associated gastric and duodenal ulcers.

S Bank, R E Greenberg, and S Zucker
Gut 1991 32: 963-964. [PDF]

This article has been cited by other articles:

• Hawkey, C J, Wilson, I, Naesdal, J, Langstrom, G, Swannell, A J, Yeomans, N D (2002). Influence of sex and Helicobacter pylori on development and healing of gastroduodenal lesions in non-steroidal anti-inflammatory drug users. Gut 51: 344-350 [Abstract] [Full Text]  
• Agrawal, N. M., Campbell, D. R., Safdi, M. A., Lukasik, N. L., Huang, B., Haber, M. M., for the NSAID-Associated Gastric Ulcer Study Group, (2000). Superiority of Lansoprazole vs Ranitidine in Healing Nonsteroidal Anti-inflammatory Drug-Associated Gastric Ulcers: Results of a Double-blind, Randomized, Multicenter Study. Arch Intern Med 160: 1455-1461 [Abstract] [Full Text]  
• Hull, M A, Thomson, J L, Hawkey, C J (1999). Expression of cyclooxygenase 1 and 2 by human gastric endothelial cells. Gut 45: 529-536 [Abstract] [Full Text]  
• Takahashi, S., Shigeta, J.-I., Inoue, H., Tanabe, T., Okabe, S. (1998). Localization of cyclooxygenase-2 and regulation of its mRNA expression in gastric ulcers in rats. Am. J. Physiol. Gastrointest. Liver Physiol. 275: G1137-G1145 [Abstract] [Full Text]  
• Shigeta, J.-I., Takahashi, S., Okabe, S. (1998). Role of Cyclooxygenase-2 in the Healing of Gastric Ulcers in Rats. J. Pharmacol. Exp. Ther. 286: 1383-1390 [Abstract] [Full Text]  
• Yeomans, N. D., Tulassay, Z., Juhasz, L., Racz, I., Howard, J. M., van Rensburg, C. J., Swannell, A. J., Hawkey, C. J., The Acid Suppression Trial: Ranitidine versus Omep, (1998). A Comparison of Omeprazole with Ranitidine for Ulcers Associated with Nonsteroidal Antiinflammatory Drugs. NEJM 338: 719-726 [Abstract] [Full Text]  
• Koch, M., Dezi, A., Ferrario, F., Capurso, L. (1996). Prevention of Nonsteroidal Anti-inflammatory Drug--Induced Gastrointestinal Mucosal Injury: A Meta-analysis of Randomized Controlled Clinical Trials. Arch Intern Med 156: 2321-2332 [Abstract]  
• Soll, A. H., Practice Parameters Committee of the American Coll, , Achord, J. L., Bozymski, G., Brooks, S., Lanza, F., Lyon, D., Meyer, G., Reinus, J., Schuster, M., Achord, J., Ofman, J., Glassman, P., Laine, L., Tytgat, G., Walsh, J. H., Graham, D. Y., Peterson, W. L. (1996). Medical Treatment of Peptic Ulcer Disease: Practice Guidelines. JAMA 275: 622-629 [Abstract]  
• Wilcox, C. M., Shalek, K. A., Cotsonis, G. (1994). Striking Prevalence of Over-the-Counter Nonsteroidal Anti-inflammatory Drug Use in Patients With Upper Gastrointestinal Hemorrhage. Arch Intern Med 154: 42-46 [Abstract]  
• Cryer, B., Feldman, M. (1992). Effects of Nonsteroidal Anti-inflammatory Drugs on Endogenous Gastrointestinal Prostaglandins and Therapeutic Strategies for Prevention and Treatment of Nonsteroidal Anti-inflammatory Drug--Induced Damage. Arch Intern Med 152: 1145-1155 [Abstract]